Gollust Keith R

Synta Pharmaceuticals Corp.

Director

Avg. Two Year Performance

(24%) Avg. Purchase Return (11%) Compound

(408%) Avg. Sale Return (125%) Compound

Holdings: 2.12M shares

Last Three Months: 04-Feb-24 -- 03-May-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Company Sentiment

Diagnostic Substances

Drugs

Two Year Chart

04-May-22 -- 03-May-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions